Routine interventions failed to provide survival benefits for early-stage major salivary gland marginal zone lymphoma in a population-based analysis
{{output}}
Major salivary gland marginal zone lymphoma (MSGMZL) is a rare malignant tumor, predominantly presenting with early-stage (I/II) lesions. Given the scarcity of evidence for treatment efficacy, a comprehensive analysis of the long-term outcomes of various thera... ...
